Chinese and western medicine compound preparation for treating acute suppurative cholangitis

A compound preparation and suppurative technology, which is applied in the field of Chinese and Western medicine compound preparations for the treatment of acute suppurative cholangitis, and can solve the problem of lack of therapeutic drugs for acute suppurative cholangitis

Inactive Publication Date: 2016-01-13
刘双英
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, there is still a lack of recognized safe and effective drugs for the treatment of acute suppurative cholangitis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] A Chinese and Western medicine compound preparation for treating acute suppurative cholangitis is prepared by the following process:

[0058] A. Raw material composition: by weight, including:

[0059] Chinese medicine raw materials: 60 parts of water vertebral wood, 45 parts of Banbianqi, 100 parts of Jinnaxiang, 80 parts of Pao Zhang fruit, 150 parts of bract leaf tree, 100 parts of kudzu root, 40 parts of mountain centipede, 20 parts of bergamot, 90 parts of elm bark, 30 parts of Artemisia chinensis, 50 parts of bald sore flower, 80 parts of Angtian lotus, 40 parts of yellow hair ear grass, 30 parts of Dengtai cabbage, 10 parts of cypress, 50 parts of hawthorn, 40 parts of sensual grass, and 30 parts of white skin , 60 parts of typhoid grass, 40 parts of dog bone wood;

[0060] Western medicine ingredients: 2 parts of polymyxin sulfate, 3 parts of salicylic acid, 1 part of doxycycline;

[0061] Excipients: 22 parts of disintegrating agent, 2 parts of lubricant, 5 p...

Embodiment 2

[0069] A Chinese and Western medicine compound preparation for treating acute suppurative cholangitis is prepared by the following process:

[0070] A. Raw material composition: by weight, including:

[0071] Raw materials of traditional Chinese medicine: 90 parts of water vertebral wood, 60 parts of Banbianqi, 130 parts of Jinnaxiang, 140 parts of Pao palm fruit, 190 parts of bract leaf tree, 150 parts of kudzu root, 60 parts of mountain centipede, 30 parts of bergamot, 110 parts of elm bark, 40 parts of Artemisia chinensis, 80 parts of bald sore flower, 90 parts of Ang Tianlian, 45 parts of yellow hair ear grass, 40 parts of Dengtai cabbage, 15 parts of sapopolamine, 60 parts of hawthorn, 50 parts of sensual grass, 40 parts of white bark , 80 parts of typhoid grass, 50 parts of dog bone wood;

[0072] Western medicine ingredients: 3 parts of polymyxin sulfate, 4 parts of salicylic acid, 1.5 parts of doxycycline;

[0073] Excipients: 28 parts of disintegrating agent, 2.5 pa...

Embodiment 3

[0081] A Chinese and Western medicine compound preparation for treating acute suppurative cholangitis is prepared by the following process:

[0082] A. Raw material composition: by weight, including:

[0083] Traditional Chinese medicine raw materials: 105 parts of water vertebral wood, 67.5 parts of Banbianqi, 150 parts of Jinnaxiang, 140 parts of pao palm fruit, 225 parts of bractia, 175 parts of kudzu root, 65 parts of mountain centipede, 35 parts of bergamot, 120 parts of elm bark, 65 parts of Heisha Artemisia, 100 parts of Tuchuang Flower, 100 parts of Ang Tian Lian, 45 parts of Yellow Ear Grass, 45 parts of Dengtai Cai, 17.5 parts of Cyclopolamine, 75 parts of Ming Hawthorn, 60 parts of Sensex Grass, 50 parts of Aphrodisiac , 80 parts of typhoid grass, 75 parts of dog bone wood;

[0084] Western medicine ingredients: 3.5 parts of polymyxin sulfate, 5 parts of salicylic acid, 2.25 parts of doxycycline;

[0085] Excipients: 31 parts of disintegrating agent, 3 parts of lubr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a Chinese and western medicine compound preparation for treating acute suppurative cholangitis. The preparation is composed of the following raw materials: traditional Chinese medicinal raw materials: root of Homonoia riparia Lour., semi-pinnated brake herb, root or leaf of Pilose Triumfetta, small-fruited balloon vine fruit, Phacellaria compressa Benth., Vitis flexuosa Thunb., PeliosanthestetaAndr.P.minorYamamoto, distillate of fingered citron fruit, Cortex Hemipteleae, arternisia ordosica, Dicranostigma leptopodum, abroma angusta, goldhair hedyotis herb, Sedum amplibracteatum K.T.Fu[S.bracteatum Diels], Anisodus carniolicoides, Fructus Chaenomelis Sinensis, polycarpae, ailanthus altissima, Vernonia cinerea and root of Common Tricalysia; and western medicine components: colistin sulfate, salicylic acid and doxycycline. Chinese herbal active ingredients are extracted and the extract is made into ultrafine powder; and the ultrafine powder is used along with the western medicine components and auxiliary materials to prepare capsules. By reasonable selection of the traditional Chinese medicines and western medicines, the formula is strict and compatibility is reasonable. The traditional Chinese medicines have effects of dispelling wind clearing heat, removing toxicity for detumescence, diminishing swelling and expelling pus, resolving tetany and relieving pain, promoting circulation of qi and dissipating dampness; and the western medicines have anti-microbial and anti-infection effects. By good synergistic effects of the traditional Chinese medicines and western medicines, the Chinese and western medicine compound preparation of the invention can effectively treat acute suppurative cholangitis, has a remarkable effect of clinical verifications and is safe and effective.

Description

technical field [0001] The invention relates to the technical field of medication for cholangitis, in particular to a compound Chinese and Western medicine preparation for treating acute suppurative cholangitis. Background technique [0002] Acute suppurative cholangitis is an acute purulent infection of the biliary tract caused by biliary obstruction (the most common being gallstone obstruction) resulting in stasis of bile and a rapid increase in the pressure within the bile duct. Infection species mainly include Gram-negative bacilli and Escherichia coli, among which Escherichia coli is the most common. The onset of this disease is sharp and dangerous, and it is one of the main causes of death of gallstone patients in my country. [0003] Acute suppurative cholangitis is mostly secondary to bile duct stones and biliary ascariasis. However, lesions such as bile duct stricture and bile duct tumors can sometimes be secondary to this disease. The above diseases cause bile d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/12A61P1/16A61P31/04A61K36/896A61K31/60A61K31/65
Inventor 刘双英刘春凤马维丰
Owner 刘双英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap